This site is part of the Siconnects Division of Sciinov Group

This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.

ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR

Registration
Event
Hybrid Event

Accelerate Ideas, Partnerships and Opportunities

Book your SLOT NOW
  • Start 9:00am - 6:00pm
  • Rome, Italy
 
 
 
 
 
 
 
 
 

About Conference

 

Sciinov Group is elated to extend an invitation to the “3rd Edition of the Global Longevity Federation” (GLF 2024), scheduled for August 12-13, 2024, as a Hybrid Event in Rome, Italy. This premier event offers both virtual and in-person participation options, catering to a global audience.

GLF 2024 is a pivotal annual gathering where Longevity Clinics, Physicians, Pharmacists, Businesses, and Investors converge to explore the latest innovations and their applications in clinical practice. This event assembles the world’s most...

Readmore

Author's Login
Abstract Tracking Tool

current speakers

Our Conference

2024 Current Speakers

Oversees the production and development of the scientific program, and are key vehicles for developing and progressing the objectives

View All Speakers

Archived Speaker

ask & questions

answer

We are always looking for new industry leaders to join our speaker faculty to deliver presentations, lead panel discussions and moderate sessions or roundtables. 

If you are interested in being considered as a speaker, submit your proposal/abstract Online

 

 

 

answer

Once your abstract got accepted, the Presenting Author of an accepted oral or poster abstract must register for the Annual Meeting (fees apply)

answer

Visas for non-GCC nationals may take several weeks to process, so avoid delay by ensuring your booking is confirmed by registering today. We accept no responsibility for denials or delays in the processing of visas.

answer

In an effort to allow for appropriate social distancing, we are taking a number of measures to reduce density.

Please be assured that the health and safety of our attendees is paramount to us. Given the latest conditions, only those fully vaccinated against COVID-19 are permitted to attend. You will be required to provide proof of vaccination at registration. Additionally, please be advised that per local guidelines in Rome, Italy, at this time masks are required in indoor public places regardless of vaccination status.


Recent Updates

16 JULY
2024

Interleukin Linked to Muscle Loss, Fat Accumulation of Aging

In a new paper appearing in Nature, the team of scientists from Duke-NUS Medical School in Singapore demonstrated in preclinical mouse studies that the protein interleukin-11 (IL11) actively promotes aging, and that giving an anti-IL11 therapy not only counteracts the deleterious effects of aging but also increases lifespan. Readmore

10 JULY
2024

UQ research reveals exercise brain boost can last for years

A longitudinal study by University of Queensland researchers has found high-intensity interval exercise improves brain function in older adults for up to 5 years. Readmore

11 JULY
2024

Nutritious diet in midlife linked to healthier aging

Eating a diet rich in fruits, vegetables, whole grains, and unsaturated fats throughout midlife may increase an individual’s odds of aging healthfully, according to a new study by researchers at Harvard T.H. Chan School of Public Health.Readmore

17 JULY
2024

Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B™ for the Treatment of Mild Alzheimer’s Disease

Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Lomecel-B™ for the treatment of mild Alzheimer’s Disease. Lomecel-B™ is a proprietary, scalable, allogeneic, investigational cellular therapy being evaluated across multiple indications, including Alzheimer’s Disease (Phase 2a completed), Aging-related Frailty (Phase 2b completed) and hypoplastic left heart syndrome (HLHS) (Phase 2b ongoing).Readmore


08:00-09:00

Registration

09:00-09:30

Opening Ceremony and Introduction

09:30-10:10

Keynote Session I

10:10-10:50

Keynote Session II

10:50-11:00

Refreshment Break

11:00-15:00

Break Out Session I

15:00-15:10

Refreshment Break

15:10-18:00

Break Out Session II

09:30-10:10

Keynote Session III

10:10-10:50

Keynote Session IV

10:50-11:00

Refreshment Break

11:00-15:00

Break Out Session III

15:00-15:10

Refreshment Break

15:10-18:00

Break Out Session IV

Get more information

make a booking now

Market Reports

Subscribe to our News & Updates